Humoral innate immune response and disease
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The humoral innate immune response consists of multiple components, including the naturally occurring antibodies (NAb), pentraxins and the complement and contact cascades. As soluble, plasma components, these innate proteins provide key elements in the prevention and control of disease. However, pathogens and cells with altered self proteins utilize multiple humoral components to evade destruction and promote pathogy. Many studies have examined the relationship between humoral immunity and autoimmune disorders. This review focuses on the interactions between the humoral components and their role in promoting the pathogenesis of bacterial and viral infections and chronic diseases such as atherosclerosis and cancer. Understanding the beneficial and detrimental aspects of the individual components and the interactions between proteins which regulate the innate and adaptive response will provide therapeutic targets for subsequent studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495 · cited 1×
“The elevation in bradykinin mediates the enhanced vascular permeability which allows cell invasion in cancer patients [200,201].”
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940 · cited 1×
“The binding of C3a and C5a to their receptors increases IL-6, which induces transcriptional changes in cell cycle progression and inhibits apoptosis [146,147].”
Complement and its role in innate and adaptive immune responses
Dunkelberger, J. R., & Song, W.-C. (2010) · Cell Research · doi:10.1038/cr.2009.139 · Cited by 1,932 · cited 1×
“A compromised humoral innate immune system increases susceptibility to bacteria [3,18].”
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744
The complement system in regulation of adaptive immunity
Carroll, M. C. (2004) · Nature Immunology · doi:10.1038/ni1113 · Cited by 1,035 · cited 1×
“Recent evidence indicates that complement plays a significant role in directing the adaptive immune response as well as in tissue regeneration [1,2].”
Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’
Avrameas, S. (1991) · Immunology Today · doi:10.1016/s0167-5699(05)80045-3 · Cited by 766 · cited 1×
“NAb are usually of the IgM isotype but may include IgG and IgA isotypes as well [8].”
An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm
Bottazzi, B., Doni, A., Garlanda, C., & Mantovani, A. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101305 · Cited by 592 · cited 1×
“Recent studies demonstrate that C1q recognizes pentraxins bound to pathogen surfaces and target the bacteria for destruction [55,56].”
Complement activation and inhibition: a delicate balance
Sjöberg, A. P., Trouw, L. A., & Blom, A. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.11.003 · Cited by 364 · cited 1×
“Recent studies demonstrate that C1q recognizes pentraxins bound to pathogen surfaces and target the bacteria for destruction [55,56].”
Regulation of complement activation by C-reactive protein
Mold, C., Gewurz, H., & Du Clos, T. W. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00007-7 · Cited by 326 · cited 1×
“Early studies indicated that CRP activates C1q of the classical complement pathway and that monomeric CRP binds the alternative complement pathway inhibitor, factor H (reviewed in [126]).”
Moalli, F., Doni, A., Deban, L., Zelante, T., Zagarella, S., Bottazzi, B., Romani, L., Mantovani, A., & Garlanda, C. (2010) · Blood · doi:10.1182/blood-2009-12-258376 · Cited by 205
Cited by
Senescent cell clearance by the immune system: Emerging therapeutic opportunities
Prata, L. G. P. L., Ovsyannikova, I. G., Tchkonia, T., & Kirkland, J. L. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2019.04.003 · Cited by 497
The porcine innate immune system: an update
Mair, K. H., Sedlak, C., Käser, T., Pasternak, A., Levast, B., Gerner, W., Saalmüller, A., Summerfield, A., Gerdts, V., Wilson, H. L., et al. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.03.022 · Cited by 264
“The humoral innate immune system is comprised of soluble plasma components that include, but are not exclusive to, complement, natural antibodies, acute phase proteins, and antimicrobial peptides as well as proteins/peptides involved in the contact system (Shishido et al., 2012).”
BackgroundInfluentialThe complement system and its role in the pathogenesis of periodontitis: current concepts
Damgaard, C., Holmstrup, P., Van Dyke, T. E., & Nielsen, C. H. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12209 · Cited by 63
Le Luyer, J., Schull, Q., Auffret, P., Lopez, P., Crusot, M., Belliard, C., Basset, C., Carradec, Q., Poulain, J., Planes, S., et al. (2021) · Animal Microbiome · doi:10.1186/s42523-021-00097-1 · Cited by 16
“These gene products are known for binding, agglutinating and neutralising bacteria [83], as well as triggering humoral immune response [84] or providing extracellular structure for pathogen adhesion through fibronectin-binding pro-”
BackgroundLe Luyer, J., Schull, Q., Auffret, P., lopez, P., Crusot, M., Belliard, C., Basset, C., Carradec, Q., Poulain, J., Planes, S., et al. (2020) · doi:10.1101/2020.08.26.247221 · Cited by 16
Metadata
- Authors
- Shishido, S. N., Varahan, S., Yuan, K., Li, X., & Fleming, S. D.
- Venue
- Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 144
- Issue
- 2
- Pages
- 142-158
- ISSN
- 1521-6616 (ISSN-L)
- OpenAlex
- W2034193686
- Cited by
- 87
- References
- 10
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.